1. GLP-1 Obesity Drug Pioneers Propose Radical Shift: Ditch GLP-1 Target for New Hormone Combo
The foundational scientists behind blockbuster obesity drugs like Zepbound are now challenging the core premise of their own success. A research team led by Richard DiMarchi and Matthias Tschöp is advancing a provocative hypothesis: targeting the GLP-1 hormone may be unnecessary for potent weight loss. Their new experi...